MetaVia Inc. is trading 17.5% down at $2.12 today as traders unwind momentum following a sharp pullback from last week’s ADA conference rally.
- Investors are fading the initial pop driven by excitement over late-breaking obesity and cardiometabolic abstracts presented at the American Diabetes Association 2026 meeting.
- Speculative biotech sentiment is cooling after the initial price spike, despite no new negative company-specific updates being reported.